Avalo Therapeutics, Inc. (AVTX) has 34 open-market insider trades by 13 insiders since 2021. Over the last six months insiders net sold $52K. The most active filer is Caissa Capital Management ltd., 10% Owner.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Armistice Capital, LLC via Steven Boyd | Dir10% Owner | — | 3 | $25.5M | 2023-02-07 |
| Armistice Capital Master Fund Ltd. | 10% Owner | — | 3 | $5.6M | 2023-06-27 |
| Steven Boyd | Dir10% Owner | — | 3 | $1.2M | 2022-03-07 |
| Mittie Doyle | — | — | 1 | $823K | 2026-08-28 |
| Caissa Capital Management ltd. | 10% Owner | — | 13 | $722K | 2023-06-26 |
| Jonathan Goldman | Dir | — | 1 | $163K | 2026-03-28 |
| Jennifer Riley | CSO | — | 1 | $52K | 2026-08-11 |
| Garry Arthur Neil | CEO | — | 3 | $30K | 2026-05-21 |
| June Sherie Almenoff | Dir | — | 1 | $13K | 2025-03-28 |
| H. Jeffrey Wilkins | Chief Medical Officer | — | 1 | $10K | 2021-12-10 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Christopher Ryan Sullivan | CFO | Sell | $202K | 2026-09-16 |
| Christopher Ryan Sullivan | CFO | Sell | $179K | 2026-09-10 |
| Mittie Doyle | — | Sell | $14K | 2026-08-28 |
| Mittie Doyle | — | Sell | $20K | 2026-08-17 |
| Christopher Ryan Sullivan | CFO | Sell | $1.5M | 2026-08-17 |
| Jennifer Riley | CSO | Sell | $52K | 2026-08-11 |
Companies that share insiders with AVTX, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| Mittie Doyle | — | Sell | $14K | 2026-08-10 |
| Mittie Doyle | — | Sell | $20K | 2026-07-27 |
| Mittie Doyle | — | Sell | $93K | 2026-06-30 |
| Mittie Doyle | — | Sell | $26K | 2026-06-23 |
| Mittie Doyle | — | Sell | $11K | 2026-05-28 |
| Mittie Doyle | — | Sell | $56K | 2026-05-15 |
| Christopher Ryan Sullivan | CFO | Sell | $449K | 2026-05-07 |
| Christopher Ryan Sullivan | CFO | Sell | $949K | 2026-05-06 |
| Mitchell Chan | Director | Sell | $72K | 2026-05-06 |